KRAS and metastatic neoplasm: Moreover, they found that a major imbalance of allelic states of KRAS (KRASMa) favoring the mutant allele over the wild-type allele occurred in only 4% of primary tumors compared to 29% in metastatic disease (Chan-Seng-Yue et al., 2020).